Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
SEC Filings
Home
SEC Filings
Filings
Filing Date
Form Type
Company
Description
AI
Link
Learn
MCP
API
Cookie Preferences
COYA · Form 4 · Pavao Mark H – Coya Therapeutics, Inc. | Signal8
Material events
Financial results
Capital raises
Insider transactions
Fund filings
Advanced filters
Any time
Sort
Filings
Filing Date
Form Type
Company
Description
AI
Link
Browse AI-analysed SEC filings
Page 1 of 78 · 7,730 total
TNL: 10-Q · periodic report
TNL · 10-Q · 2026-10-27
AUBN: 8-K · earnings release
AUBN · 8-K · 2026-10-27
WHR: 10-Q · periodic report
WHR · 10-Q · 2026-10-27
DPRO: 6-K · other
DPRO · 6-K · 2026-10-27
AMUB: 424B3 · prospectus supplement
AMUB · 424B3 · 2026-10-27
WFF: 6-K · amendment
WFF · 6-K · 2026-10-27
HLT: 10-Q · periodic report
HLT · 10-Q · 2026-10-27
WORX: 424B3 · prospectus supplement
WORX · 424B3 · 2026-10-27
FSBC: 8-K · earnings release
FSBC · 8-K · 2026-10-27
TGHL: 6-K · leadership change
TGHL · 6-K · 2026-10-27
AIT: 8-K · earnings release
AIT · 8-K · 2026-10-27
DFNS: 8-K · material agreement
DFNS · 8-K · 2026-10-27
AIIO: 424B3 · prospectus supplement
AIIO · 424B3 · 2026-10-27
SXC: 8-K · earnings release
SXC · 8-K · 2026-10-27
AIIO: 6-K · reverse split
AIIO · 6-K · 2026-10-27
SHG: 6-K · dividend
SHG · 6-K · 2026-10-27
MRLN: 8-K · leadership change
MRLN · 8-K · 2026-10-27
CHSN: 6-K · amendment
CHSN · 6-K · 2026-10-27
ITW: 8-K · earnings release
ITW · 8-K · 2026-10-27
ACU: 8-K · earnings release
ACU · 8-K · 2026-10-27
BB: 8-K · leadership change
BB · 8-K · 2026-10-27
BAER: 8-K · material agreement
BAER · 8-K · 2026-10-27
CFBK: 8-K · earnings release
CFBK · 8-K · 2026-10-27
LECO: 8-K · earnings release
LECO · 8-K · 2026-10-27
DORM: 10-Q · periodic report
DORM · 10-Q · 2026-10-27
BWIN: 8-K · earnings release
BWIN · 8-K · 2026-10-27
THFF: 8-K · earnings release
THFF · 8-K · 2026-10-27
GOVX: 8-K · debt financing
GOVX · 8-K · 2026-10-27
CBU: 8-K · earnings release
CBU · 8-K · 2026-10-27
TTGT: 8-K · earnings release
TTGT · 8-K · 2026-10-27
CSTE: 6-K · litigation
CSTE · 6-K · 2026-10-27
LFWD: 8-K · leadership change
LFWD · 8-K · 2026-10-27
KEY: 424B5 · prospectus supplement
KEY · 424B5 · 2026-10-27
PMEC: 6-K · other
PMEC · 6-K · 2026-10-27
MMA: 6-K · other
MMA · 6-K · 2026-10-27
AEC: 6-K · regulatory action
AEC · 6-K · 2026-10-27
GGB: 6-K · earnings release
GGB · 6-K · 2026-10-27
PLRZ: 6-K · clinical trial
PLRZ · 6-K · 2026-10-27
SMPL: 10-K · periodic report
SMPL · 10-K · 2026-10-27
ITRI: 8-K · earnings release
ITRI · 8-K · 2026-10-27
EARN: 8-K · offering registration
EARN · 8-K · 2026-10-27
VNET: 6-K · debt financing
VNET · 6-K · 2026-10-27
ESQ: 8-K · earnings release
ESQ · 8-K · 2026-10-27
SCTH: 8-K · material agreement
SCTH · 8-K · 2026-10-27
HEPS: 6-K · other
HEPS · 6-K · 2026-10-27
ARTV: 8-K · other
ARTV · 8-K · 2026-10-27
PEW: 8-K · acquisition merger
PEW · 8-K · 2026-10-27
CMND: 6-K · clinical trial
CMND · 6-K · 2026-10-27
BFH: 424B5 · prospectus supplement
BFH · 424B5 · 2026-10-27
ALT: 8-K · leadership change
ALT · 8-K · 2026-10-27
CDT: 8-K · material agreement
CDT · 8-K · 2026-10-27
MRP: 8-K · earnings release
MRP · 8-K · 2026-10-27
EEFT: 8-K · earnings release
EEFT · 8-K · 2026-10-27
FCX: 8-K · earnings release
FCX · 8-K · 2026-10-27
RLYB: 10-Q · periodic report
RLYB · 10-Q · 2026-10-27
ACLS: 8-K · leadership change
ACLS · 8-K · 2026-10-27
DAVI: 6-K · acquisition merger
DAVI · 6-K · 2026-10-27
HUBB: 8-K · earnings release
HUBB · 8-K · 2026-10-27
PCAR: 8-K · earnings release
PCAR · 8-K · 2026-10-27
CAC: 8-K · earnings release
CAC · 8-K · 2026-10-27
ECL: 8-K · earnings release
ECL · 8-K · 2026-10-27
SFD: 10-Q · periodic report
SFD · 10-Q · 2026-10-27
ENLV: 6-K · delisting
ENLV · 6-K · 2026-10-27
ENTX: 8-K · leadership change
ENTX · 8-K · 2026-10-27
SFD: 8-K · earnings release
SFD · 8-K · 2026-10-27
RADX: 6-K · proxy statement
RADX · 6-K · 2026-10-27
IMRN: 6-K · earnings release
IMRN · 6-K · 2026-10-27
CBC: 8-K · earnings release
CBC · 8-K · 2026-10-27
CTS: 8-K · earnings release
CTS · 8-K · 2026-10-27
SLBK: 8-K · earnings release
SLBK · 8-K · 2026-10-27
RLNDF: 6-K · other
RLNDF · 6-K · 2026-10-27
WVE: 10-Q · periodic report
WVE · 10-Q · 2026-10-27
CVLT: 8-K · earnings release
CVLT · 8-K · 2026-10-27
NWFL: 8-K · earnings release
NWFL · 8-K · 2026-10-27
NAMI: 6-K · leadership change
NAMI · 6-K · 2026-10-27
ZURA: 8-K · earnings release
ZURA · 8-K · 2026-10-27
GVH: 6-K · other
GVH · 6-K · 2026-10-27
ZURA: 10-Q · periodic report
ZURA · 10-Q · 2026-10-27
NAUT: 10-Q · periodic report
NAUT · 10-Q · 2026-10-27
WVE: 8-K · earnings release
WVE · 8-K · 2026-10-27
SNSE: 8-K · leadership change
SNSE · 8-K · 2026-10-27
KNSA: 8-K · earnings release
KNSA · 8-K · 2026-10-27
BA: 8-K · earnings release
BA · 8-K · 2026-10-27
WSO: 8-K · earnings release
WSO · 8-K · 2026-10-27
HCA: 8-K · earnings release
HCA · 8-K · 2026-10-27
SPGI: 8-K · earnings release
SPGI · 8-K · 2026-10-27
IPHA: 6-K · clinical trial
IPHA · 6-K · 2026-10-27
PHAR: 6-K · earnings release
PHAR · 6-K · 2026-10-27
IQV: 8-K · earnings release
IQV · 8-K · 2026-10-27
GWRE: 8-K · acquisition merger
GWRE · 8-K · 2026-10-27
CNL: 6-K · clinical trial
CNL · 6-K · 2026-10-27
GLXY: 8-K · earnings release
GLXY · 8-K · 2026-10-27
SHW: 8-K · earnings release
SHW · 8-K · 2026-10-27
RGEN: 8-K · earnings release
RGEN · 8-K · 2026-10-27
AMT: 8-K · earnings release
AMT · 8-K · 2026-10-27
SOFI: 8-K · earnings release
SOFI · 8-K · 2026-10-27
ABG: 8-K · earnings release
ABG · 8-K · 2026-10-27
VBNK: 6-K · regulatory action
VBNK · 6-K · 2026-10-27
IAG: 6-K · other
IAG · 6-K · 2026-10-27
SMPL: 8-K · earnings release
SMPL · 8-K · 2026-10-27
1
2
3
4
8
12
16
20
24
28
32
36
40
44
48
52
56
60
64
68
72
76
78
Next ›
